UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medical supplies trade with China turn to black in 2017
Korea’s exports of medical and pharmaceutical products to China increased t...
by Nam Doo-hyun
|
2017-12-04 16:09
라인
Cord blood biotech firms enjoy stock price gains this year
Korean biotech firms with major pipelines in cord blood banks and umbilical...
by Nam Doo-hyun
|
2017-12-04 15:02
라인
Tego Science shares surge on robust earnings
The surging of Tego Science shares on Kosdaq on Thursday drew attention, pr...
by Nam Doo-hyun
|
2017-12-01 11:48
라인
Sexual scandal at Pfizer Korea belatedly uncovered
After hospitals came under fire for senior physicians’ sexual violence agai...
by Nam Doo-hyun
|
2017-11-30 16:29
라인
Nanomedicine market to grow rapidly: report
With researchers actively using nanotechnology to treat diseases, the nanom...
by Nam Doo-hyun
|
2017-11-29 16:47
라인
‘Weak digital healthcare sector might be eaten by foreign capital’
“Multinational companies are leading the local digital healthcare industry....
by Nam Doo-hyun
|
2017-11-29 14:39
라인
Hospital wins patent in VR treatment for cognitive disorders
A local hospital is drawing attention by winning a patent in cognitive reha...
by Nam Doo-hyun
|
2017-11-27 16:05
라인
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed
On Korea’s secondary stock market, foreign investors net bought the shares ...
by Nam Doo-hyun
|
2017-11-27 13:13
라인
Clinical trials on CAR-T cell therapies surge in two years
The number of clinical trials on CAR-T (chimeric antigen receptor T-cell) t...
by Nam Doo-hyun
|
2017-11-24 15:53
라인
Zuellig Pharma Korea CEO treats workers like ‘dogs and pigs’: union
The labor union of Zuellig Pharma Korea has launched a series of one-man pr...
by Nam Doo-hyun
|
2017-11-21 13:43
라인
‘Pharmaceuticals’ main mission is R&D, not marketing’
One can find quite a few people working not just in multinational pharmaceu...
by Nam Doo-hyun
|
2017-11-20 16:37
라인
ViroMed aims phase 1 trial on CAR-T cell therapy by 2020-2022
ViroMed said it would conduct a phase 1 clinical trial on CAR-T (chimeric a...
by Nam Doo-hyun
|
2017-11-17 13:53
라인
Earthquake hits biopharmaceutical factories in Pohang
With a magnitude 5.4 quake hitting Pohang in North Gyeongsang Province, ind...
by Nam Doo-hyun
|
2017-11-16 15:55
라인
New US guideline adds 6.5 million to Korean hypertension patients
As the American Heart Association and the American College of Cardiology re...
by Nam Doo-hyun
|
2017-11-16 14:38
라인
InBody stocks rise on record Q3 earnings
The share prices of InBody, a manufacturer of body composition analyzers, a...
by Nam Doo-hyun
|
2017-11-14 15:49
라인
Do adverse effects of statin increase if more people know about them?
A research result about the “nocebo effect” of statin, the base material fo...
by Nam Doo-hyun
|
2017-11-14 06:30
라인
Biopharmaceutical firms rank high in Kosdaq market cap
Biopharmaceutical firms are showing strong performance on South Korea’s tec...
by Nam Doo-hyun
|
2017-11-13 15:25
라인
Big-3 companies take up half of healthcare market cap
Combined market capitalization of Celltrion Group, Samsung BioLogics and Ha...
by Nam Doo-hyun
|
2017-11-09 11:21
라인
Daewoong salespersons unhappy about management system
Daewoong Pharmaceutical is known for its strong marketing ability among loc...
by Nam Doo-hyun
|
2017-11-08 16:48
라인
ViroMed, Reyon in legal battle over gene therapy patent rights
The exclusive contract between ViroMed and Reyon Pharmaceutical to jointly ...
by Nam Doo-hyun
|
2017-11-07 14:10
-
이전
11
12
13
14
15
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top